Affordable Access

Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .

Authors
  • Özgül, Nejat
  • Köse, Mehmet Faruk
  • Keskin, Hüseyin Levent
  • Turan, Ahmet Taner
  • Karalök, Mustafa Alper
  • Üreyen, Işin
  • Borani, Nurettin
  • Tulunay, Haklu Gökhan
Type
Published Article
Journal
Turkish journal of medical sciences
Publication Date
Jan 01, 2014
Volume
44
Issue
2
Pages
212–219
Identifiers
PMID: 25536727
Source
Medline
License
Unknown

Abstract

The addition of epirubicin to the standard treatment protocol yielded an improvement in the DFS rate that was not statistically significant and caused a tolerable increase in toxicity.

Report this publication

Statistics

Seen <100 times